The reference standard for TIV was definite enhancing soft tissue in vein, regardless of visualization of a parenchymal mass and visible adjacent primary tumor in liver parenchyma (Fig. ) [15, 16], then with the surgical pathologic confirmation or three months imaging follow-up remained the diagnosis of TIV. All FLLs were diagnosed by either histopathology (surgery or puncture biopsy pathology, the biopsy procedure were described in Additional file 1: Section S1) or composite imaging reference standard. The composite standard for HCC was FLLs with CECT or MRI scans characterized by the arterial phase hyperenhancement (APHE) and washout appearance in the portal venous phase or delayed phase in a size greater than 1 cm in diameter [20]. Other malignant lesions were diagnosed by histopathology only.
The way of intrahepatic vein invasion. CEUS: Contrast-Enhanced Ultrasound, TIV: Tumor in vein
Copyright and License information: The Author(s) ©2022 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.